These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1931143)

  • 21. A randomized trial of aspirin and beta-carotene among U.S. physicians.
    Hennekens CH; Eberlein K
    Prev Med; 1985 Mar; 14(2):165-8. PubMed ID: 3900975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final report on the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
    Christen WG; Glynn RJ; Ajani UA; Schaumberg DA; Chew EY; Buring JE; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Aug; 119(8):1143-9. PubMed ID: 11483080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.
    Glynn RJ; Buring JE; Manson JE; LaMotte F; Hennekens CH
    Arch Intern Med; 1994 Dec 12-26; 154(23):2649-57. PubMed ID: 7993148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).
    Cook NR; Le IM; Manson JE; Buring JE; Hennekens CH
    Cancer Causes Control; 2000 Aug; 11(7):617-26. PubMed ID: 10977106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of beta carotene and age-related cataract in US physicians.
    Christen WG; Manson JE; Glynn RJ; Gaziano JM; Sperduto RD; Buring JE; Hennekens CH
    Arch Ophthalmol; 2003 Mar; 121(3):372-8. PubMed ID: 12617708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost and efficiency in clinical trials: the U.S. Physicians' Health Study.
    Buring JE; Hennekens CH
    Stat Med; 1990; 9(1-2):29-33. PubMed ID: 2345836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the effect of the run-in on the power of the Physicians' Health Study.
    Lang JM; Buring JE; Rosner B; Cook N; Hennekens CH
    Stat Med; 1991 Oct; 10(10):1585-93. PubMed ID: 1947514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
    Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH
    J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.
    Stampfer MJ; Buring JE; Willett W; Rosner B; Eberlein K; Hennekens CH
    Stat Med; 1985; 4(2):111-6. PubMed ID: 4023472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I.
    Christen WG; Ajani UA; Schaumberg DA; Glynn RJ; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Mar; 119(3):405-12. PubMed ID: 11231774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians.
    Howell TH; Ridker PM; Ajani UA; Hennekens CH; Christen WG
    J Am Coll Cardiol; 2001 Feb; 37(2):445-50. PubMed ID: 11216961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study.
    Cook NR; Hebert PR; Manson JE; Buring JE; Hennekens CH
    Arch Intern Med; 2000 Apr; 160(7):921-8. PubMed ID: 10761956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.
    Cook NR; Cole SR; Hennekens CH
    Am J Epidemiol; 2002 Jun; 155(11):1045-53. PubMed ID: 12034583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Height and incidence of cardiovascular disease in male physicians.
    Hebert PR; Rich-Edwards JW; Manson JE; Ridker PM; Cook NR; O'Connor GT; Buring JE; Hennekens CH
    Circulation; 1993 Oct; 88(4 Pt 1):1437-43. PubMed ID: 8403290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians.
    Guallar E; Hennekens CH; Sacks FM; Willett WC; Stampfer MJ
    J Am Coll Cardiol; 1995 Feb; 25(2):387-94. PubMed ID: 7829792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmation of self-reported cataract in the Physicians' Health Study.
    Christen WG; Glynn RJ; Seddon JM; Manson JE; Buring JE; Hennekens CH
    Ophthalmic Epidemiol; 1994 Jun; 1(2):85-91. PubMed ID: 8790615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction.
    Young FE; Nightingale SL; Temple RA
    JAMA; 1988 Jun; 259(21):3158-60. PubMed ID: 3367492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.